Maryland HB 1194: Health – Drug Cost Commission

Status: Favorable Report by Finance (as of 2018-04-09)

State: Maryland · Session: 2018 · Bill: HB 1194

Subjects: Public Health, Health Care Facilities and Regulation, Appeals, Attorney General, Committees and Commissions, Contracts, Disclosure, Drugs, Electronic Government, Ethics, Gifts, Hearings, Industry and Technology, Notices, Pharmacy Benefits Managers, Prices, Public Information, Reimbursement Rates, Reports, Revenue and Taxes, Salaries and Compensation, State Employees, Witnesses

Sponsors: Pena-Melnyk, A. Miller, A. Washington, Ali, Anderson, Atterbeary, B. Barnes, Barron, Barve, Beidle, Branch, Bromwell, Brooks, C. Howard, Carey, Carr, Chang, Clippinger, Conaway, Cullison, D. Barnes, Davis, Dumais, Ebersole, Fennell

View Maryland HB 1194 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.